150 related articles for article (PubMed ID: 7018767)
21. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor.
O'Reilly RJ; Dupont B; Pahwa S; Grimes E; Smithwick EM; Pahwa R; Schwartz S; Hansen JA; Siegal FP; Sorell M; Svejgaard A; Jersild C; Thomsen M; Platz P; L'Esperance P; Good RA
N Engl J Med; 1977 Dec; 297(24):1311-8. PubMed ID: 21351
[TBL] [Abstract][Full Text] [Related]
22. Selection of related and unrelated bone marrow donors.
Goldmann SF
Transplant Proc; 1977 Mar; 9(1):507-11. PubMed ID: 17197
[No Abstract] [Full Text] [Related]
23. The use of cell separation techniques and isantibody to host antigens in the treatent of severe combined immunodeficiency disease with HL-A incompatible maternal marrow.
Gelfand EW; Phillips RA; Miller RG; McCulloch EA; Rosen FS
Exp Hematol; 1974; 2(3):122-30. PubMed ID: 4156326
[No Abstract] [Full Text] [Related]
24. Treatment of severe combined immunodeficiency by a small number of pretreated nonmatched marrow cells.
Huang SW; Ammann AJ; Levy RL; Hong R; Bach FH
Transplantation; 1973 Jan; 15(1):174-6. PubMed ID: 4145722
[No Abstract] [Full Text] [Related]
25. Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.
Friedrich W; Goldmann SF; Vetter U; Fliedner TM; Heymer B; Peter HH; Reisner Y; Kleihauer E
Lancet; 1984 Apr; 1(8380):761-4. PubMed ID: 6143084
[TBL] [Abstract][Full Text] [Related]
26. Depletion of complement during graft-versus-host reaction in a severe combined immunodeficiency patient after receiving a mismatched marrow transplant.
Ballow M; Day NK; Good RA
Transplantation; 1973 Oct; 16(4):380-2. PubMed ID: 4147640
[No Abstract] [Full Text] [Related]
27. Immunological dysregulation after bone-marrow transplantation in patients with severe combined immunodeficiency.
Virelizier JL; Durandy A; Ballet JJ; Griscelli C
Pathol Biol (Paris); 1978 Jan; 26(1):21-2. PubMed ID: 29268
[No Abstract] [Full Text] [Related]
28. Bone marrow transplantation.
Geary CG; Evans DI; Scarffe JH
Br J Hosp Med; 1982 Apr; 27(4):393, 395-7, 399. PubMed ID: 7042020
[No Abstract] [Full Text] [Related]
29. Transplantation in severe combined immune deficiency.
South MA
Cutis; 1980 Aug; 26(2):130, 134. PubMed ID: 6996938
[No Abstract] [Full Text] [Related]
30. Immunologic reconstitution in severe combined immunodeficiency with HL-A-incompatible bone marrow graft: donor selection by mixed lymphocyte culture.
Dupont B; Andersen V; Ernst P; Faber V; Good RA; Hansen GS; Henriksen K; Jensen K; Juhl F; Killmann SA; Koch C; Muller-Berat N; Park BH; Svejgaard A; Thomsen M; Wiik A
Transplant Proc; 1973 Mar; 5(1):905-8. PubMed ID: 4144470
[No Abstract] [Full Text] [Related]
31. [Graft vs host reaction (GvHR) following perinatal maternofetal transfusion or following blood cell substitution: the diagnostic value of HLA testing].
Goldmann SF; Ebell W; Blütters-Sawatzki R; Eiermann T; Kreth W; Wölpl A; Friedrich W
Beitr Infusionther Klin Ernahr; 1987; 18():321-5. PubMed ID: 3439986
[No Abstract] [Full Text] [Related]
32. The Graft-versus-Host Reaction: a pathogenetic mechanism of experimental and human disease.
Seemayer TA
Perspect Pediatr Pathol; 1979; 5():93-136. PubMed ID: 43960
[No Abstract] [Full Text] [Related]
33. Y chromatin as indicator of chimaerism following bone marrow transplantation in severe combined immunodeficiency.
Nielsen H; Koch C; Müller-Berat N; Philip J
Scand J Immunol; 1973; 2(4):327-31. PubMed ID: 4588903
[No Abstract] [Full Text] [Related]
34. Severe combined immunodeficiency: transplantation approaches for patients lacking an HLA genotypically identical sibling.
O'Reilly RJ; Pahwa R; Dupont B; Good RA
Transplant Proc; 1978 Mar; 10(1):187-99. PubMed ID: 345560
[No Abstract] [Full Text] [Related]
35. A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency.
O'Reilly RJ; Kirkpatrick D; Kapoor N; Collins N; Brochstein J; Kernan N; Flomenberg N; Pollack M; Dupont B; Lopez C
Prog Clin Biol Res; 1985; 193():327-42. PubMed ID: 3911216
[No Abstract] [Full Text] [Related]
36. Studies on non HL-A cytotoxic and blocking factor in a patient with immunological deficiency successfully reconstituted by bone marrow transplantation.
Jeannet M; Rubinstein A; Pelet B
Tissue Antigens; 1973; 3(6):411-6. PubMed ID: 4130126
[No Abstract] [Full Text] [Related]
37. Histoincompatible bone marrow transplants in humans.
Clift RA; Storb R
Annu Rev Immunol; 1987; 5():43-64. PubMed ID: 3297107
[No Abstract] [Full Text] [Related]
38. [Treatment of patients subjected to bone marrow transplantation].
Bedarida G
Riv Emoter Immunoematol; 1970; 17(1):35-43. PubMed ID: 4400641
[No Abstract] [Full Text] [Related]
39. Reconstitution of Clq after bone marrow transplantation in patients with severe combined immunodeficiency.
Ballow M; Day NK; Biggar WD; Park BH; Yount WJ; Good RA
Clin Immunol Immunopathol; 1973 Nov; 2(1):28-35. PubMed ID: 4272769
[No Abstract] [Full Text] [Related]
40. Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.
Friedrich W; Goldmann SF; Ebell W; Blütters-Sawatzki R; Gaedicke G; Raghavachar A; Peter HH; Belohradsky B; Kreth W; Kubanek B
Eur J Pediatr; 1985 Jul; 144(2):125-30. PubMed ID: 3899661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
